Home
>
National Drug Code (NDC)
>
Lisinopril
Lisinopril - 63304-535-01 - (Lisinopril)
Drug Information of Lisinopril
| Product NDC: | 63304-535 |
| Proprietary Name: | Lisinopril |
| Non Proprietary Name: | Lisinopril |
| Active Ingredient(s): | 40 mg/1 & nbsp; Lisinopril |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Lisinopril
| Product NDC: | 63304-535 |
| Labeler Name: | Ranbaxy Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA075944 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20020702 |
Package Information of Lisinopril
| Package NDC: | 63304-535-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (63304-535-01) |
NDC Information of Lisinopril
| NDC Code | 63304-535-01 |
| Proprietary Name | Lisinopril |
| Package Description | 100 TABLET in 1 BOTTLE (63304-535-01) |
| Product NDC | 63304-535 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Lisinopril |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20020702 |
| Marketing Category Name | ANDA |
| Labeler Name | Ranbaxy Pharmaceuticals Inc. |
| Substance Name | LISINOPRIL |
| Strength Number | 40 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
